Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

COMT inhibitor disclosed by Roche

June 21, 1996

Taro's anticonvulsant drug undergoes development

June 21, 1996

Pierre Fabre describes 5-HT1 receptor ligands

June 21, 1996

FDA approves Organon's Remeron

June 21, 1996

RPR describes RPR-107880 synthesis

June 21, 1996

Cypros conferred SBIR grant to develop CPC-111 prodrugs

June 14, 1996

Activase cleared by FDA for ischemic stroke

June 14, 1996

More glutamate antagonists from NeuroSearch

June 14, 1996

Novo Nordisk synthesizes AMPA antagonists

June 14, 1996

Glutamate antagonists reported by BASF

June 14, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 7, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 7, 2024.
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...
Sanofi bets on Resalis’ oligonucleotide RES-010 for obesity
BioWorld
After missing out on the glucagon-like peptide 1 obesity market, Sanofi SA is prospecting for next-generation drugs and is making a strategic equity investment in...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.